Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
36.00
-0.20 (-0.56%)
Apr 23, 2025, 4:15 PM CET
-30.50%
Market Cap 167.88M
Revenue (ttm) 350.00K
Net Income (ttm) -18.71M
Shares Out 4.66M
EPS (ttm) -4.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,398
Average Volume 1,801
Open 36.00
Previous Close 36.00
Day's Range 34.80 - 36.00
52-Week Range 33.00 - 56.80
Beta 0.98
RSI 51.33
Earnings Date Apr 17, 2025

About Poltreg

Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases. It engages in the research and development of therapies for the treatment of type 1 diabetes in children, and multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 23
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

In 2024, Poltreg's revenue was 350,000, a decrease of -74.98% compared to the previous year's 1.40 million. Losses were -18.71 million, 38.1% more than in 2023.

Financial Statements

News

There is no news available yet.